32 results match your criteria: "Japan Self Defense Force Central Hospital[Affiliation]"
Biomed Pharmacother
October 2003
Internal Medicine, Japan Self Defense Force Central Hospital, Saitama, Japan
Autonomic imbalance is thought to play an important role in the pathogenesis of neurally mediated syncope (NMS). Heart rate variability (HRV) indices and fractal dimension derived from 24 h ambulatory electrocardiogram (AECG) reflects the cardiac autonomic activity and provides useful information for understanding the pathogenesis of NMS. In this study, we sought the cardiac autonomic activity and the status of fractal dimension in daily life in patients with NMS.
View Article and Find Full Text PDFRyoikibetsu Shokogun Shirizu
February 2003
Department of Neurology, Japan Self Defense Force Central Hospital.
No To Shinkei
July 2002
Department of Neurosurgery, Japan Self Defense Force Central Hospital, 1-2-24 Ikejiri, Setagayaku, Tokyo 154-8532, Japan.
An early diagnosis of the outcome of patients with cerebrovascular disease is important for selecting the optimal treatment strategy. The purpose of this study was to estimate the prognosis of Wallerian degeneration on MRI in stroke patients with hemiparesis. The subjects consisted of 87 stroke patients, 50 hemorrhagic patients and 37 ischemic patients, who were evaluated by MRI at 1 to 6,275 days after stroke onset.
View Article and Find Full Text PDFRyoikibetsu Shokogun Shirizu
January 2002
Department of Neurology, Japan Self Defense Force Central Hospital.
Ryoikibetsu Shokogun Shirizu
January 2002
Department of Neurology, Japan Self Defense Force Central Hospital.
Am J Gastroenterol
July 1993
Department of Internal Medicine, Japan Self Defense Force Central Hospital, Tokyo.
Nippon Ganka Gakkai Zasshi
October 1992
Department of Ophthalmology, Japan Self Defense Force Central Hospital, Setagaya-ku.
Phase I studies, as divided into two stages, were conducted in healthy volunteers with the ophthalmic solution of UF-021, a novel prostaglandin metabolite-related compound, that was reported to exhibit potent intraocular pressure (IOP)-reducing activity in various species of animals. In the first stage, the vehicle as well as UF-021 ophthalmic solutions at concentration of 0.03%, 0.
View Article and Find Full Text PDF